ArticleCureus2025
Diffuse Low-Grade Glioma With Spontaneous Radiological Regression: A Case to Be Followed.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Low-grade gliomas (LGGs) are slow-growing, infiltrative brain tumors with a tendency to progress over time. Spontaneous regression of LGG is an exceptionally rare phenomenon, with only one case documented in the literature. The mechanisms underlying this phenomenon remain unclear but may involve immunological responses, spontaneous apoptosis, vascular remodeling, or hormonal influences, and may open up some new therapeutic perspectives for the future. We report the case of a 21-year-old woman with no medical history who presented with headaches, visual disturbances, and progressive left-sided hemiparesis. Brain MRI revealed a diffuse glioma in the splenium of the corpus callosum, extending into the parieto-rolandic region. A stereotactic biopsy confirmed the diagnosis of a diffuse LGG (not otherwise specified (NOS)). The patient received only symptomatic treatment with anticonvulsants and five days of corticosteroids, without adjuvant therapy. At the six-month follow-up, she showed significant neurological improvement, and imaging demonstrated partial tumor regression. By the one-year follow-up, the lesion had nearly disappeared, with no signs of recurrence. A histopathological review confirmed the initial diagnosis, ruling out other possible differential diagnoses. Spontaneous regression of diffuse LGG remains an extremely rare event with unclear underlying mechanisms. This case underscores the complexity of glioma biology and highlights the need for further research to explore potential predictive biomarkers and alternative therapeutic strategies based on the pathways involved in spontaneous regression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.